MCM
ABMD

MV Capital Management’s Abiomed Inc ABMD Stock Holding History

MV Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17
Closed -$4K – 688
2022
Q3 		$4K Buy
17
+2
+13% +$540 ﹤0.01% 577
2022
Q2 		$4K Buy
15
+1
+7% +$270 ﹤0.01% 591
2022
Q1 		$5K Sell
14
-1
-7% -$308 ﹤0.01% 604
2021
Q4 		$5K Buy
15
+5
+50% +$1.69K ﹤0.01% 605
2021
Q3 		$3K Buy
10
+3
+43% +$1.02K ﹤0.01% 662
2021
Q2 		$2K Buy
+7
New +$2.15K ﹤0.01% 643

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MV Capital Management's ABMD Position: Q4 2022 in Review

MV Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 17 shares — an estimated $4K sold.

MV Capital Management first reported a position in ABMD in Q2 2021 and held it in 6 quarters. The position peaked at $5K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • MV Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • MV Capital Management sold 17 Abiomed Inc shares in Q4 2022, an estimated $4K.
  • MV Capital Management first reported a position in Abiomed Inc in Q2 2021 and held it in 6 quarters.
  • MV Capital Management's Abiomed Inc position peaked at $5K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on MV Capital Management's 13F filing for Q4 2022, filed 27 Jan 2023.